Lawrence Kinet

Mr. Lawrence Henry Neil Kinet, BSc, MBA, is a veteran of the medical devices industry and has a successful track record and solid business experience. He has over 40 years of international experience in the field of healthcare services and technology, with a track record of building businesses through profitable sales growth and raising venture and public equity capital, including an IPO. Mr. Kinet served as Group Chief Executive Officer of LMA International NV from October 2008 to June 2010 (later acquired by Teleflex). He served as the President and Chief Executive Officer of CellCoTec Ltd. He served as President and Group Managing Director of Smiths Medical, a $1.3 billion company, and was an Executive Director of Smiths Group plc from February 2000 to July 2005. Mr. Kinet served as the Chairman, President, and Chief Executive Officer of Aksys Ltd. from 1994 to 1999, during which time he took Aksys through an IPO on to NASDAQ. From 1991 to 1994 he also served as the Chairman and Chief Executive Officer of Oculon Corp. He served as Non-Executive Chairman of Endosense SA (later acquired by St. Jude). He served as Chairman of Oxford Immunotec Ltd. until October 2008 (currently on NASDAQ). He served as Healthcare Consultant of The Kensington Group, where he served as Managing Partner from 1989 to 1991. In the early part of his career he served in a number of senior posts at Baxter International Inc., including General Manager of a Travenol division in the Middle East; President of Baxter’s Americas and Pacific division; and Corporate Vice President and President, World Trade Group, with operating and strategic responsibility for $1.5 billion in sales and 12,000 employees. He currently serves as Non-Executive Director of Kromek Group plc (listed on AIM) and also currently serves as Chairman of Metrasens Ltd. Mr. Kinet obtained his Bachelor of Science at the University of Birmingham in the UK in 1968 and his MBA at the University of Chicago in 1970. He resides in Tucson, Arizona.